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Abstract
Background: Growing evidence indicates that the risk of obstetric and perinatal outcomes is higher in women
with assisted reproductive technology (ART). However, there is little known about pregnancy related
complications and co-morbidity in gestational diabetes mellitus (GDM) following singleton pregnancies
achieved by ART in comparison with spontaneous conception (SC).
Methods: Two hundred sixty singleton pregnant women conceived by ART and 314 pregnant women
conceived by spontaneous conception (SC) were participated in this prospective cohort study. All participants
were enrolled after GDM screening through one-step oral glucose tolerance test (OGTT) and then grouped
into GDM and non-GDM groups. Women were followed for pregnancy outcomes including pregnancy-induced
hypertension (PIH), preeclampsia, antepartum hemorrhage (APH), cesarean section (CS), preterm birth (PTB), intrauterine
growth restriction (IUGR), being small or large for gestational age (SGA or LGA), macrosomia, low birth weight (LBW),
respiratory distress, neonatal hypoglycemia, NICU admission and perinatal mortality from antenatal visits to delivery.
Confounding factors were adjusted in logistic regression model in order to estimate adjusted odds ratios (aORs).
(Continued on next page)
* Correspondence: rohosseini@yahoo.com; baradaran.hr@iums.ac.ir
2Department of Endocrinology and Female Infertility, Reproductive
Biomedicine Research Center, Royan Institute for Reproductive Biomedicine,
ACECR, Number 12, East Hafez Avenue, Bani Hashem Street, Resalat Highway,
Tehran 16635-148, Iran
1Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran
University of Medical Sciences (IUMS), Firouzeh St., South Vali- Asr Ave., Vali-
Asr Sq., Tehran 15937-16615, Iran
Full list of author information is available at the end of the article
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Kouhkan et al. BMC Pregnancy and Childbirth          (2018) 18:495 
https://doi.org/10.1186/s12884-018-2115-4
(Continued from previous page)
Results: Among 260 ART and 314 SC, 135 and 152 women were GDM women, respectively. Higher maternal age and pre-
gravid BMI, shorter duration of gestation and lower gestational weight gain were observed in GDM groups (ART-GDM and
SC-GDM) compared to those of the SC group. ART-GDM group had a higher risk (95% confidence interval) of obstetric
complications including PIH [aOR:7.04 (2.24–22.15)], preeclampsia [aOR:7.78 (1.62–37.47)], APH [aOR:3.46 (1.28–9.33)],
emergency CS [aOR:2.64 (1.43–4.88)], and perinatal outcomes such as PTB [aOR:3.89 (1.51–10.10)], LBW [aOR:3.11 (1.04–9.30)]
and NICU admission [aOR:4.36 (1.82–10.45)], as well as neonatal hypoglycemia [aOR: 4.91 (1.50–16.07)], compared to SC
group. SC-GDM group showed a higher risk of PIH [aOR: 4.12 (1.31–12.89)], emergency CS [aOR: 2.01 (1.09–3.73] and LGA
[aOR: 5.20 (1.07–25.20)], compared to SC group. Additionally, ART group had a higher risk of PIH [aOR: 3.46(1.02–11.68),
preeclampsia 5.29 (1.03–27.09), and NICU admission [aOR: 2.53 (1.05–6.09)] compared to SC. Insulin requirement (41.8% vs.
25.7%) was significantly higher in ART-GDM group compared to SC-GDM group.
Conclusion: The findings of this study suggest that GDM occurring after ART conception increases the risk of adverse
obstetric and perinatal outcomes.
Keywords: Gestational diabetes mellitus, Assisted reproductive technology, Complications, Obstetric, Perinatal, Neonatal
Background
Gestational diabetes mellitus (GDM) is a common
metabolic disorder of pregnancy, which has unfavorable
and negative effects (e.g. occurrence of preeclampsia,
macrosomia, low birth weight and preterm birth) on
maternal and fetal health [1, 2]. Population studies have
reported a GDM prevalence of 1–14% [3]. The Hypergly-
cemia and Adverse Pregnancy Outcome (HAPO) study
indicated that higher levels of maternal glucose are related
to increased risks of adverse pregnancy outcomes [4].
During the last decades, the number of pregnancies
conceived using assisted reproductive technologies
(ART) has increased globally [5]. A recent meta-analysis
showed that infertility history and treatment are linked
to increased risk of GDM, particularly in Asians [6].
Also, the wide range of GDM prevalence (11–40%)
among those undergoing ART was reported [7–10].
Previous meta-analyses demonstrated that perinatal
outcomes in pregnancies achieved by ART are poorer
than those of pregnancies conceived naturally [11, 12].
Despite considerable improvement in ART protocols
and laboratory techniques as well as enhanced practices
such as elective single embryo transfer and frozen
embryo transfer cycles, recent evidence indicated similar
consequences [7, 13].
Though several investigations have studied maternal
and perinatal outcomes of ART conception [8, 13–16]
or outcomes of natural pregnancy complicated by
GDM [17–20], to the best of our knowledge, no
prospective cohort study has yet compared GDM -re-
lated outcomes between assisted conception and
spontaneous pregnancies. A recent retrospective study
done by Szymanska et al. [21], compared maternal
and neonatal outcomes of GDM between women who
underwent in vitro fertilization (IVF) and non-IVF
women. However, consequences of ART pregnancies
complicated by GDM are yet to be understood.
Considering the increasing number of pregnancies
achieved by ART, and increased awareness of GDM-
related morbidities, it is of crucial importance to
explore pregnancy-related complications in GDM
pregnancies following ART. Therefore, the present
study compared obstetric and perinatal outcomes of
GDM between singleton pregnancies achieved by
ART and those of spontaneous pregnancies, in order
to have a clearer understanding of maternal and
infant health under such conditions; the results of
this study would be beneficial for policy makers with
respect to healthcare interventions required for
prevention and control of GDM among ART
population.
Materials and methods
This prospective observational cohort study was carried out
in Royan Institute and maternity teaching hospital located
in Tehran. The participants gave written informed consent
for the data collection and ethical approval was granted by
Institutional Review Boards and the Ethics Committees of
Royan Institute, Tehran, Iran and Iran University of
Medical Sciences, Tehran, Iran (date:2014-09-4, ethics code:
IR.ACECR.ROYAN.REC.1393.2 and date:2015-09-4, ethics
code: IR.IUMS.REC.1396.25469). This study was performed
from November 2014 to January 2017.
The ART pregnancies were singleton pregnancies
following IVF /intra-cytoplasmic sperm injection
(IVF/ICSI) or ICSI cycles that treated at infertility
clinic affiliated to Royan Institute. Women with
spontaneous conception (SC) were those did not have
a history of infertility (time to pregnancy < 1 years)
and/or infertility treatments, and referred to Arash
Women’s Hospital (affiliated to Tehran University of
Medical Sciences, Tehran, Iran).
Singleton pregnant women aged 20–42 years, who
conceived via ART or SC, were enrolled. All participants
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with a history of chronic diseases, multiple pregnancies,
pre-pregnancy diabetes mellitus, and glucose intolerance
as well as those who were receiving hypoglycemic agents
[e.g. metformin for treatment of polycystic ovary
syndrome (PCOS)], or corticosteroids as well as those
with pregnancies with vanishing embryos or selective
fetal reduction, were excluded from the study. Also,
women with a history of infertility or infertility treat-
ment were excluded from the SC group.
All women were evaluated for pre-existing diabetes
by measurement of fasting blood sugar (FBS) during
the first trimester of pregnancy and the results were
recorded in hospital registry. Then, all participants
were screened for GDM using one-step oral glucose
tolerance test (OGTT done by oral administration of
75 g glucose) according to ADA/IAPDSG (American
Diabetes Association/International Association of the
Diabetes and Pregnancy Study Groups) criteria at
24–28 weeks of gestation except for high-risk women
(high-risk subjects were those with a history of
GDM and PCOS, age ≥ 35 years, and pre-gravid
obesity). Both groups (ART and SC) were stratified
into two groups (GDM and non-GDM) based on the
results of OGTT. In the present study, 600 eligible
singleton pregnant women conceived via ART or SC
were enrolled at 24–28 weeks of gestation after
screening for GDM. Twelve women from ART group
and 14 women from SC group were excluded as they
selected other centers for further prenatal care
follow up or unwilling to continue the study. Finally,
574 singleton pregnant women were grouped into
four groups namely, ART, ART with GDM (ART-GDM),
SC with GDM (SC-GDM), and SC (Fig. 1).
Demographic and clinical data were obtained from
patients’ medical records and hospital databases and
through face-to-face interviews. All participants were
followed for obstetric and perinatal outcomes of preg-
nancy. The data was obtained by telephone follow-up,
clinical evaluations and checking hospital records by a
trained physician from antenatal visits to 2 weeks after
childbirth. All participants received prenatal care in
Royan Institute and Arash Women’ hospital and the
deliveries were performed at a university-based
hospital for high-risk maternal-fetal medicine.
The following variables were included in the final
analysis: maternal age; gravidity (primigravida: the
first pregnancy); parity (nulliparous: no previous
births); pre-pregnancy weight, height and pre-preg-
nancy BMI [pre-pregnancy weight (kg)/ (height (m))
2]; gestational age at delivery (in weeks), type of
GDM treatment (diet and/or insulin) during preg-
nancy, as well as gestational weight gain (GWG).
In both groups (ART and SC), GDM patients were
referred to a dietitian for dietary counseling. After 2
weeks, blood sugar profile (BSP) in terms of FBS and
postprandial (i.e. 2-h after breakfast, lunch and
dinner) serum glucose levels, was determined. In case
of FBS < 95 mg/dl and 2-h postprandial blood sugar
levels < 120 mg/dl, dietary management alone was
used. Patients with higher blood sugar levels were
GDM Screening  
Without GDM diagnosis  
(n= 135)  
With GDM diagnosis  
(n= 137) 
With GDM diagnosis 
(n= 160) 
Without GDM diagnosis 
(n= 168) 
ART (n= 125) 
Loss to follow up (n=10) 
ART -GDM (n= 135) 
Loss to follow up (n=2) 
SC-GDM (n= 152) 
Loss to follow up (n=8) 
SC (n= 162) 
Loss to follow up (n=6) 
Obstetric and perinatal outcomes evaluation 
Pregnancies conceived by 
Assisted reproduction technology (ART)  
Pregnancies conceived by  
Spontaneous conception (SC)   
GDM Screening  
Fig. 1 Flow chart of the study population
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treated with subcutaneous injections of rapid-acting
insulin and/or long-acting insulin. Blood sugar levels
were monitored twice a week.
The following obstetric complications were assessed:
pregnancy-induced hypertension (PIH; as defined by
systolic blood pressure > 140 and/or diastolic blood pres-
sure > 90 mmHg after 20 weeks of pregnancy), pre-
eclampsia (pregnancy-induced hypertension associated
with proteinuria ≥100 mg/dl as shown by urine analysis
or ≥ 300 mg/24 h), antepartum hemorrhage (APH; any
bleeding in the second or third trimesters due to
placenta praevia, abruption, and uterine bleeding), and
emergency cesarean (i.e. not planned cesarean).
Perinatal data including newborn’s birth weight, height
and sex, as well as neonatal morbidity and mortality,
were recorded at delivery. Apgar scores at 1 min and 5
min were retrieved from the delivery records. Perinatal
outcomes including macrosomia (birth weight > 4000 g),
low birth weight (LBW; birth weight < 2500 g), small for
gestational age (SGA; birth weight < 10th percentile for
a given gestational age), large for gestational age (LGA;
birth weight > 90th percentile for a given gestational
age), preterm birth (PTB; birth sooner than gestation
week 37), neonatal hypoglycemia (blood glucose< 45mg/
dl), neonatal intensive care unit (NICU) admission,
intrauterine growth restriction (IUGR; growth below the
third percentile for gestational age), respiratory distress
and perinatal mortality (combination of still birth and
fetal and neonatal death) were also collected.
Statistical analysis
Data analysis was done using IBM SPSS Statistics for
Windows, Version 22.0 (IBM Crop., Armonk, NY, USA).
On the basis of the incidence rate of PIH, preeclampsia
and PTB as primary outcomes [9, 22, 23], the final sam-
ple size (with significance level α = 0.05 and power 1 − β
= 0.8) was calculated and 130 women were enrolled in
each group. In this study, continuous variables were
expressed as mean ± standard deviation and categorical
variables were expressed as number (percentage).
Chi-square test and one-way ANOVA were used to
compare baseline characteristics among groups where
appropriate. To examine the effects of GDM and ART
on pregnancy complications, logistic regression analysis
was performed to estimate crude odds ratios (OR) and
adjusted odds ratios (adjusted OR = aOR) with 95%
confidence intervals (CI) and adjusted for maternal age,
parity, and pre-pregnancy BMI. All statistical tests were
two-sided and level of significance was set at 0.05.
Results
After evaluation, 574 singleton pregnancies including
260 ART conception (135 subjects with and 125 with-
out GDM diagnosis), and 314 spontaneous conception
(152 subjects with and 162 without GDM diagnosis)
were enrolled (Fig. 1). The baseline characteristics of
the four groups are compared in Table 1. Women in
SC group were significantly younger than the women of
other groups (p < 0.05). Pre-gravid BMI was significantly
higher in GDM groups (ART-GDM and SC-GDM) than
non-GDM groups (ART and SC) (P < 0.01). Pre-gravid
obesity (BMI ≥ 30 kg/m2) was significantly higher in
ART-GDM group compared to non-GDM groups
(ART and SC) (p < 0.001). The rate of previous history
of GDM was significantly higher in SC-GDM group.
Women in ART-GDM group had significantly higher
rates of previous history of PCOS than the other
groups (p < 0.001). The rate of maternal age of ≥35
years was significantly higher in GDM groups (ART-GDM
and SC-GDM) than the SC group (p < 0.001). Together, a
higher number of high-risk women were observed in
ART-GDM. Gestational age at delivery was significantly
lower among ART-GDM subjects than non-GDM groups
(i.e. ART and SC groups). Gestational weight gain was
significantly higher in non-GDM groups (i.e. ART and
SC groups) than ART-GDM and SC-GDM groups.
There was no significant difference between SC and
ART in terms of GWG, gestational age at GDM
screening and pre-pregnancy BMI (P > 0.05). There
was no significant difference between SC-GDM and
ART-GDM in maternal age, gestational age at
delivery, pre-gravid BMI nor GWG (P > 0.05). Concur-
rent dietary management and insulin administration
was required in 39 (25.7%) of women of SC-GDM
group vs. 57 (41.8%) of women of ART-GDM group
(P < 0.004). The rate of insulin therapy was signifi-
cantly higher in ART-GDM subjects than SC-GDM
individuals.
Risk of obstetric, perinatal and neonatal complications
Table 2 presents the obstetric outcomes observed in
the four groups of the present study, along with the
risk of each outcome relative to that in women of the
SC group. Logistic regression showed that the risk of
PIH was increased in the ART [adjusted odds ratio
(aOR) 3.46, 95% confidence interval (CI), 3.46 (1.02,
11.68)], ART-GDM [aOR: 7.04, 95% CI: (2.24–22.15)]
and GDM [aOR: 4.12, 95% CI: (1.31–12.89)] groups
in comparison to the SC group. The ART [aOR: 5.29,
95% CI: (1.03–27.09)] and ART-GDM [aOR: 7.78,
95% CI: (1.62–37.47)] singleton pregnancies had
higher risk of preeclampsia in comparison to SC pregnan-
cies. It was found that the risk of APH was significantly
increased only in ART-GDM group in comparison to SC
group [aOR: 3.46, 95% CI: (1.28–9.33)]. Moreover, the risk
of emergency CS was significantly higher in GDM groups
(ART-GDM and SC-GDM) compared to the SC group.
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Perinatal and neonatal outcomes are shown in
Table 3. The risk of preterm birth, LBW and
neonatal hypoglycemia in the ART-GDM group were
increased in comparison to the SC group [(aOR:
3.89, 95% CI: (1.51–10.10)), (aOR: 3.11, 95% CI:
(1.04–9.30)), and (aOR: 4.91, 95% CI: (1.50–16.07)),
respectively]. Furthermore, the SC-GDM pregnancies
compared to the SC pregnancies, had a significantly
higher risk of developing LGA [aOR: 5.20, 95% CI:
(1.07–25.20)]. In addition, the ART-GDM [aOR: 4.36,
95% CI: (1.82–10.45)] and ART [aOR: 2.53, 95% CI:
(1.05–6.09)] pregnancies indicated a higher risk of
NICU admission in comparison to SC pregnancies.
The risk of other evaluated perinatal complications
(e.g. SGA, respiratory distress, macrosomia and IUGR)
did not show any differences among the study groups.
Perinatal mortality was observed in 5 (3.7%) women of
the ART-GDM, 2 (1.3%) women of the SC-GDM and 1
(0.6%) woman of the SC groups (P = 0.052). Neonatal
hypoglycemia was observed in 5 (3.3%) neonates of the
SC-GDM and 15 (11.5%) neonates of the ART-GDM
groups (P < 0.004). Apgar scores < 7 at 5 min were
observed in 2 (1.5%) neonates of the ART-GDM and 6
(4.1%) neonates of the SC-GDM groups (P < 0.004).
Apgar scores < 7 at 5 min were not observed in the SC
group.
Table 4 shows the pairwise comparison of adverse
pregnancy outcomes in different groups. The results
showed that the ART-GDM group had higher risks of
emergency CS, PTB and neonatal hypoglycemia in
comparison to the ART group. Additionally, ART-
GDM group had higher risks of preeclampsia, NICU
admission and neonatal hypoglycemia compared to
the SC-GDM group.










Maternal age (yr.) (Mean ± SD) 30.28 ± 4.93 32.11 ± 4.95 31.63 ± 5.49 28.81 ± 7.43 < 0.001*
Gestational age at GDM screening (wk.) 25.6 ± 3.5 22.7 ± 6.9 24.9 ± 5.6 24.6 ± 3.1 0< 001a
Gestational age at delivery (wk.)
(Mean ± SD)
38.40 ± 1.15 37.78 ± 1.52 38.34 ± 1.47 39.05 ± 1.14 < 0.001b
Gravidity, n (%)
1 97 (77.6) 80 (59.3) 53 (34.9) 85 (52.5) < 0.001
≥ 2 28 (22.4) 55 (40.7) 99 (65.1) 77 (47.5)
Parity, n (%)
0 113 (90.4) 116 (85.9) 63 (41.4) 98 (60.5) < 0.001
≥ 1 12 (9.6) 19 (14.1) 89 (58.6) 64 (39.5)
Pre-gravid BMI (kg/m2) (Mean ± SD) 24.49 ± 3.95 27.38 ± 3.93 26.07 ± 4.93 24.14 ± 4.35 < 0.001c
Gestational weight gain (kg) (Mean ± SD) 15.03 ± 6.05 10.93 ± 5.09 11.57 ± 5.52 14.42 ± 6.12 < 0.001d
Previous history of PCOS, n (%) 10(8) 34 (25.2) 7 (7.3) 6(3.7) < 0.001e
Maternal age≥ 35 years 25(20) 38(28.2) 49(32.2) 22(13.7) 0.001 f
Pre-gravid obesity (BMI≥ 30 kg/m2), n (%) 14(11.4) 33(24.6) 25(16.9) 17(10.6) 0.004g
Previous history of GDM, n (%) 1(0.8) 4 (3) 21 (13.8) 1(0.6) < 0.001h
GDM gestational diabetes mellitus, SC spontaneous conception, ART assisted reproductive technology. All of P-values for quantitative variables were determined
by post-hoc analysis (LSD)
*ART vs. ART-GDM (P = 0.01), ART-GDM vs. SC-GDM (P = 0.5), ART -GDM vs. SC (P < 0.001), ART vs. SC (P = 0.03), SC-GDM vs. SC (P < 0.001), ART vs.
SC-GDM (P = 0.06)
aART vs. ART-GDM (P < 0.001). ART-GDM vs. SC -GDM (P < 0.001), ART -GDM vs. SC (P < 0.001), ART vs. SC (P = 0.1), SC -GDM vs. SC (P = 0.6), ART vs. SC
-GDM (P = 0.2)
bART vs. ART-GDM (P = 0.01), ART-GDM vs. SC –GDM = (P = 0.5), ART -GDM vs. SC (P < 0.001), ART vs. SC (P = 0.03), SC -GDM vs. SC (P < 0.001), ART vs. SC-
GDM (P = 0.06)
cART vs. ART-GDM (P < 0.001) ART-GDM vs. SC- GDM (P = 0.1), ART -GDM vs. SC (P < 0.001), ART vs. SC (P = 0.5), SC- GDM vs. SC (P < 0.001), ART vs. SC
-GDM (P = 0.01)
dART vs. ART-GDM (P < 0.001), ART-GDM vs. SC- GDM (P = 0.3), ART -GDM vs. SC (P < 0.001), ART vs. SC (P = 0.4), SC –GDM vs. SC (P < 0.001), ART vs. SC-
GDM (P < 0.001)
eART vs. ART-GDM (P < 0.001). ART-GDM vs. SC -GDM (P < 0.001), ART -GDM vs. SC (P < 0.001), ART vs. SC (P = 0.6), SC -GDM vs. SC (P = 0.1), ART vs. SC
-GDM (P = 0.2)
fART vs. ART-GDM (P = 0.126), ART-GDM vs. SC-GDM (P = 0.452), ART -GDM vs. SC (P = 0.002), ART vs. SC (P = 0.152), SC-GDM vs. SC (P < 0.001), ART vs.
SC-GDM (P = 0.022)
gART vs. ART-GDM (P = 0.006), ART-GDM vs. SC-GDM (P = 0.109), ART -GDM vs. SC (P = 0.001), ART vs. SC (P = 0.826), SC-GDM vs. SC (P = 105), ART vs.
SC-GDM (P = 0.198)
hART vs. ART-GDM (P = 0.205), ART-GDM vs. SC-GDM (P = 0.001), ART -GDM vs. SC (P = 0.118), ART vs. SC (P = 0.854), SC-GDM vs. SC (P < 0.001), ART vs.
SC-GDM (P = 0.001)
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As it is shown in Table 5, ART subjects compared to
non-ART ones, had higher risks of PIH, preeclampsia,
APH, NICU admission, and neonatal hypoglycemia.
Moreover, GDM individuals compared to non-GDM
ones, had higher risks of PIH, emergency CS, preterm
birth, LGA and neonatal hypoglycemia.
Discussion
In this prospective cohort study, pregnant women con-
ceived via ART were compared with women with SC, in
terms of obstetric and perinatal outcomes of GDM.
Three main findings were as follows: Shorter durations
of gestation and lower GWG were observed in GDM
groups (ART-GDM and SC-GDM) compared to SC;
ART-GDM pregnancies had higher risk of PIH,
preeclampsia, APH and emergency CS compared to SC;
Also, ART-GDM group had higher risk of perinatal and
neonatal outcomes with respect to PTB, LBW, NICU
admission, and neonatal hypoglycemia compared to SC.
The risk of LGA was significantly higher in the
SC-GDM group compared to SC group.
In the current study, mothers in SC group were
significantly younger than the other groups. Moreover,
rate of pre-gravid BMI in GDM groups (ART-GDM and
SC-GDM) was significantly higher than those of
non-GDM groups (ART and SC). Conversely, GDM
groups had significantly lower total GWG compared to
non-GDM groups, which was potentially due to more
strict weight and diet management during pregnancy, as
well as lower gestational age at delivery. Previous studies
found decreasing total GWG with increasing pre-gravid
BMI, but higher rate of mothers with extreme GWG in
overweight group [24–26]. However, since, in the
present study, GWG was not evaluated based on BMI as
explained by Institute of Medicine (IOM) recommenda-
tion, we do not have enough evidence to fully discuss
our results [27].
According to the present study, over 85% of ART
subjects (ART and ART-GDM) were nulliparous.
Insulin administration in ART-GDM group (41.8%)
was significantly higher than that of SC-GDM group
(25.7%). In a recent study, insulin was given to 28.1%
of women with GDM [17]. Insulin resistance is
considered the main etiology of GDM [28]. It was
shown that infertile women especially those with
PCOS, exhibit markedly higher levels of insulin resist-
ance and oxidative stress [29, 30].
One of our main findings was significantly increased
risks of obstetric outcomes including PIH, preeclamp-
sia, APH and emergency CS in ART-GDM group as
compared to SC. Both ART groups had higher risks
of PIH and preeclampsia; also, both GDM groups had
higher risks of PIH and emergency CS compared to
SC. Although little evidence in available concerning
the adverse pregnancy outcomes of GDM following
ART treatment, there are several reviews and
meta-analyses supporting the hypotheses that single-
ton pregnancy after ART poses higher risks of
obstetric outcomes when compared with natural
conception [7, 13, 31, 32]. Our data showed that PIH
rate in GDM-ART women was higher (19.1%) than
women in ART (8%), SC-GDM (10.7%) and SC (2.5%)
groups. Previously, Szymanska et al. showed higher
rates of preeclampsia in IVF-GDM group (36 women)









Pregnancy-induced hypertension (PIH), n (%) 10 (8.0) 25 (19.1) 16 (10.7) 4 (2.5)
OR (95% CI) 3.41 (1.04–11.15)* 9.26 (3.13–27.36)* 4.69 (1.53–14.36)* Ref. group
Adjusted OR (95% CI) 3.46 (1.02–11.68)* 7.04 (2.24–22.15)* 4.12 (1.31–12.89)* Ref. group
Preeclampsia, n (%) 7 (5.6) 15 (11.5) 7 (4.7) 2 (1.2)
OR (95% CI) 4.72 (0.96–23.11) 10.28 (2.31–45.83)* 3.89 (0.80–19.04) Ref. group
Adjusted OR (95% CI) 5.29(1.03–27.09)* 7.78(1.62-37.47)* 2.80 (0.56–14.10) Ref. group
Antepartum hemorrhage (APH), n (%) 11 (8.8) 21 (16.0) 11 (7.3) 6 (3.7)
OR (95% CI) 2.49 (0.90–6.94) 4.93 (1.93–12.62)* 2.04 (0.74–5.67) Ref. group
Adjusted OR (95% CI) 2.24 (0.78–6.40) 3.46 (1.28–9.33)* 1.80 (0.63–5.14) Ref. group
Emergency Cesarean Section, n (%) 29 (23.2) 51 (39.2) 32 (21.8) 24 (15.1)
OR (95% CI) 1.70 (0.93–3.10) 3.63 (2.08–6.35)* 1.57 (0.87–2.81) Ref. group
Adjusted OR (95% CI) 1.24 (0.67–2.32) 2.64 (1.43–4.88)* 2.01 (1.09–3.73)* Ref. group
GDM gestational diabetes mellitus, SC spontaneous conception, ART assisted reproductive technology, PIH pregnancy induced hypertension
OR Crude Odds Ratio, CI Confidence Interval
OR were adjusted for maternal age, parity and pre-pregnancy BMI
Ref. means reference group
*P < 0.05 was considered significant
Kouhkan et al. BMC Pregnancy and Childbirth          (2018) 18:495 Page 6 of 11
compared to non-IVF women with GDM (137 women)
(8.3% vs. 3.6%, respectively) [21]. Moreover, Ashrafi et al.
reported higher incidence of PIH in IVF/ICSI group
compared to SC (21 vs. 7%, respectively) [9]. In a similar
way, Tandberg et al. [33] reported that ART elevates the
risk of preeclampsia and it might be even worsened by
parity. Nevertheless, Watanabe et al. [34] indicated that
the relationship between IVF and preeclampsia might be
confounded by residual unmeasured factors.
Furthermore, our findings demonstrated that women
with GDM (ART-GDM and SC-GDM) had a higher risk
of emergency CS. Consistently, previous evidence
showed that GDM is positively correlated with emer-
gency CS, particularly among nulliparous GDM women
and LGA infants [35, 36]. Moreover, increased risk of
obstetric hemorrhage in singleton birth after ART and
GDM pregnancies was reported [37, 38]. Though it is
not fully understood, several factors including specific
infertility and ART characteristics, maternal factors, and
metabolic disturbance or a combination of these factors,
have been linked to pregnancy-related complications in
ART-GDM subjects [13, 21, 39–41]. During fertilization









Preterm Birth (PTB), n (%) 9 (7.2) 23 (17.3) 13 (8.7) 7 (4.3)
OR (95% CI) 1.71 (0.62–4.72) 4.60 (1.90–11.10)* 2.09 (0.81–5.38) Ref. group
Adjusted OR (95% CI) 1.53 (0.54–4.35) 3.89 (1.51–10.10)* 2.13 (0.81–5.63) Ref. group
IUGR n (%) 12 (9.6) 14 (10.8) 10 (6.7) 5 (3.1)
OR (95% CI) 3.27 (1.12–9.55) 3.72 (1.30–10.61) 2.20 (0.73–6.59) Ref. group
Adjusted OR (95% CI) 2.63 (0.88–7.89) 2.92 (0.96–8.93) 2.57 (0.83–7.93) Ref. group
Small for gestational age (SGA), n (%) 18 (14.4) 20 (15.3) 9 (6.0) 18 (11.2)
OR (95% CI) 1.34 (0.66–2.69) 1.43 (0.72–2.83) 0.51 (0.22–1.17) Ref. group
Adjusted OR (95% CI) 1.14 (0.55–2.37) 1.34 (0.62–2.87) 0.62 (0.27–1.46) Ref. group
Large for gestational age (LGA), n (%) 3 (2.4) 7 (5.3) 9 (6.0) 2 (1.2)
OR (95% CI) 1.95 (0.32–11.88) 4.49 (0.92–21.98) 5.07 (1.08–23.88)* Ref. group
Adjusted OR (95% CI) 2.19 (0.34–14.03) 5.08 (0.92–28.15) 5.20(1.07–25.20)* Ref. group
Macrosomia n (%) 3 (2.4) 4 (3.1) 7 (4.7) 4 (2.5)
OR (95% CI) 0.97 (0.21–4.39) 1.25 (0.31–5.08) 1.92 (0.55–6.70) Ref. group
Adjusted OR (95% CI) 1.01 (0.21–4.90) 1.21 (0.26–5.66) 1.88 (0.51–6.83) Ref. group
Low birth weight (LBW), n (%) 10 (8.0) 16 (12.2) 8 (5.3) 5 (3.1)
OR (95% CI) 2.7 (0.90–8.15) 4.34 (1.55–12.19)* 1.76 (0.56–5.50) Ref. group
Adjusted OR (95% CI) 1.99 (0.65–6.08) 3.11 (1.04–9.30)* 2.23 (0.70–7.14) Ref. group
NICU admission n (%) 18 (14.4) 27 (20.8) 12 (8.0) 9 (5.6)
OR (95% CI) 2.82 (1.22–6.52)* 4.40 (1.99–9.74)* 1.46 (0.60–3.57) Ref. group
Adjusted OR (95% CI) 2.53 (1.05–6.09)* 4.36 (1.82–10.45)* 1.59 (0.64–3.97) Ref. group
Respiratory distress n (%) 7 (5.6) 15 (11.5) 12 (8.1) 15 (9.3)
OR (95% CI) 0.58 (0.23–1.46) 1.27 (0.60–2.70) 0.85 (0.39–1.89) Ref. group
Adjusted OR (95% CI) 0.48 (0.18–1.26) 1.02 (0.44–2.34) 0.96(0.42–2.18) Ref. group
Neonatal hypoglycemia, n (%) 4(3.2) 15(11.5) 5(3.3) 5(3.1)
OR (95% CI) 1.02(0.27–3.90) 4.04(1.43–11.45)* 1.07(0.30-3.77) Ref. group
Adjusted OR (95% CI) 1.17(0.29–4.72) 4.91(1.50–16.07)* 0.94(0.24-3.70) Ref. group
Perinatal mortality, n (%) 0 5(3.7) 2(1.3) 1(0.6)
OR (95% CI) 1 6.19(0.71–53.66) 2.15(0.19–23.92) Ref. group
Adjusted OR (95% CI) 1 5.56(0.55–56.65) 2.23(0.19–25.87) Ref. group
GDM gestational diabetes mellitus, SC spontaneous conception, ART assisted reproductive technology, PIH pregnancy induced hypertension, IUGR Intrauterine
growth restriction; NICU neonatal intensive care unit
OR Crude Odds Ratio, CI Confidence Interval
ORs were adjusted for maternal age, parity and pre-pregnancy BMI
Ref. means reference group
*P < 0.05 was considered significant
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and preimplantation development, these factors may
contribute to intracellular metabolic and epigenetic
modifications which may eventually induce deleterious
consequences to prenatal development and post-natal
growth [42].
Intrestingly, we observeed that ART-GDM pregnan-
cies had significantly increased risks of adverse
perinatal outcomes including PTB, LBW and NICU
admission compared to naturally conceived ones after
adjustment for potential confounding factors. Further-
more, both GDM groups had higher risks of LGA
compared to the reference group and this difference
was statistically significant when comparing SC-GDM
group and the reference group. GDM is considered
an important risk factor for fetal macrosomia and
LGA newborn especially in women with untreated or
undetected GDM [43]. Our results showed that
compared to spontaneously conceived pregnancies,
ART-GDM pregnancies are delivered 2 weeks earlier
and those conceived by ART and SC-GDM are
delivered 1 week earlier. Lower rates of macrosomia,
LGA and GWG in ART-GDM group may be legiti-
mized by shorter duration of pregnancy and higher
rate of PTB.
The present data showed higher rates of PTB (17.3%)
and LBW (12.2%) in ART-GDM compared to the other
three groups. The worldwide prevalence of PTB and LBW
among IVF/ICSI pregnancies was found to be 10.9 and
8.7%, respectively [13]. In a recent meta-analysis of cohort
studies, Cavoretto et al. showed high incidence of spontan-
eous PTB in singleton IVF/ICSI pregnancies compared to
those conceived naturally (10.1 vs. 5.5%, respectively); odds
ratio (OR), 1.75; 95% CI, 1.50–2.03) [44]. Wisborg et al.
[45] found that the risk of PTB in subfertile and fertile sub-
jects is quite similar, and the risk of PTB in IVF/ICSI sub-
jects is related to the ART treatment. They found no
association between IVF/ICSI and the risk of LBW or
NICU admission rate. It was indicated that genetic and en-
vironmental factors, medical conditions of mother or fetus,
ART methods, behavior and socioeconomic elements, and
iatrogenic prematurity may contribute to PTB in ART [46].
Our findings showed an association between ART-GDM
and elevated odds of PTB and LBW. Nonetheless, such
associations were not observed in ART groups. This may
be partially explained by dissociation between ART and
GDM-ART in the current study as previous studies did not
discriminate ART from ART-GDM and/or other co-
comorbidities.
Our results demonstrated that the neonates of ART
groups, particularly ART-GDM group, had higher risks of
NICU admission. Furthermore, higher rates of PTB, IUGR,
SGA, LBW and emergency CS were observed in ART
group, though their associations with ART were not statisti-
cally significant. This may be due to small sample size of
our study. In addition, better healthcare may explain higher
rates of NICU admission in ART group.
Table 4 Pairwise comparisons of obstetric and perinatal outcomes among study population




PIH, OR adjusted (95% CI) 2.09 (0.91–4.81) 1.83 (0.79–4.27) 0.79 (0.30–2.11)
Preeclampsia, OR adjusted (95% CI) 1.45 (0.53–3.99) 3.31(1.03–10.64) * 1.56 (0.41–5.89)
Antepartum hemorrhage, OR adjusted (95% CI) 1.57(0.69–3.57) 1.88(0.74–4.79) 1.54(0.53–4.50)
Emergency CS, OR adjusted (95% CI) 1.95 (1.08–3.50) * 1.27(0.68–2.39) 1.43 (0.74–2.77)
Perinatal outcomes
Preterm birth, OR adjusted (95% CI) 2.46(1.04–5.85) * 1.60(0.67–3.84) 0.84 (0.30–2.38)
IUGR, OR adjusted (95% CI) 1.04(0.43–2.52) 0.96(0.34–2.69) 1.05(0.39–2.86)
Small for gestational age, OR adjusted (95% CI) 1.05(0.50–2.22) 1.82(0.70–4.73) 1.89(0.74–4.84)
Large for gestational age, OR adjusted (95% CI) 2.54(0.58–11.10) 1.13(0.33–3.87) 0.55(0.12–2.53)
Macrosomia, OR adjusted (95% CI) 1.39(0.27–7.14) 0.71(0.16–3.22) 0.63(0.13–3.01)
Low birth weight, OR adjusted (95% CI) 1.53(0.62–3.74) 1.48(0.52–4.18) 1.14(0.38–3.41)
NICU admission, OR adjusted (95% CI) 1.91(0.93–3.93) 2.94(1.23–7.05) * 1.42(0.57–3.53)
Respiratory distress, OR adjusted (95% CI) 2.29(0.84–6.23) 1.09(0.42–2.80) 0.44(0.15–1.28)
Neonatal hypoglycemia, OR adjusted (95% CI) 4.68(1.04–15.65) * 6.53(1.77–24.16) * 2.02(0.36–11.43)
Perinatal mortality, OR adjusted (95% CI) 1 3.07(0.41–22.77) 1
GDM gestational diabetes mellitus, SC spontaneous conception, ART assisted reproductive technology, PIH pregnancy induced hypertension, IUGR Intrauterine
growth restriction, NICU neonatal intensive care unit
OR Crude Odds Ratio, CI Confidence Interval
ORs were adjusted for age, parity and pre-pregnancy body mass index
*P < 0.05 was considered significant
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In the current study, a higher rate of perinatal mortality
(3.7%) was observed in ART-GDM group. Furthermore, a
higher rate of neonatal hypoglycemia was observed in
ART-GDM groups (11.5%) compared to SC-GDM (3.3%).
Insulin requirement rate was higher in ART-GDM group
possibly due to higher insulin resistance in ART-GDM
group.
Our data indicated that both ART versus non-ART preg-
nancies and GDM versus non-GDM pregnancies are
closely related to higher risks of pregnancy- related compli-
cations. Of note, ART-GDM pregnancies were associated
with higher risks of emergency CS, PTB, and neonatal
hypoglycemia compared to ART pregnancies alone. The
current study confirmed that ART-GDM pregnancy was
related to higher risks of adverse pregnancy outcomes com-
pared to both non-GDM ART and SC-GDM. In this
research, there were no significant differences between
SC-GDM and ART-GDM in terms of maternal age, gesta-
tional age at delivery, pre-pregnancy BMI and gestational
weight gain, albeit obstetric and perinatal outcomes were
more prevalent in ART-GDM compared to SC-GDM
which might be caused by ART treatment. However, litera-
ture lacks sufficient evidence to show possible correlations
between GDM and ART treatment and the underlying
mechanisms. Pinborg et al. in a systematic review, discussed
parameters which affect perinatal risks in ART singletons
and categorized them in four major groups namely,
subfertility per se, controlled ovarian hyperstimulation,
laboratory procedures and number of embryos transferred
[31]. Therefore, recent strategies such as milder ovarian
stimulation, single embryo transfer, improvements of lab
techniques and utilization of better culture media have
been taken to overcome such problems.
So far, there has been no prospective cohort study evalu-
ating obstetric and perinatal outcomes of GDM following
ART. To the best of our knowledge, the present research is
the first observational cohort study conducted in a
GDM-ART group. Nevertheless, the present study had a
small sample size. Therefore, it is urgent to perform such
an experiment in a larger population. Further research is
needed to confirm increased risk of obstetric and perinatal
complications after ART-GDM and also determine which
aspects of ART induce adverse pregnancy outcomes
following GDM and how this risk can be minimized.
Conclusion
In conclusion, singletons pregnancies conceived by
ART-GDM have higher risk of adverse obstetric and
perinatal outcomes compared to SC (for PTB, LBW,
NICU admission and neonatal hypoglycemia). In
addition, ART-GDM has higher risk of emergency CS,
PTB, and neonatal hypoglycemia compared to ART
alone. SC-GDM pregnancies have higher risk of LGA
compared to SC.
Table 5 Interaction between ART and GDM in obstetrics and perinatal outcomes
Variables ART vs. Non-ART GDM vs. Non-GDM
Obstetrics outcomes
PIH, adjusted OR (95% CI) 2.09 (1.05–4.14)* 2.68 (1.38–5.20)*
Preeclampsia, adjusted OR (95% CI) 3.40 (1.34–8.66)* 1.77 (0.76–4.12)
Antepartum hemorrhage, adjusted OR (95% CI) 2.04(1.01–4.11)* 1.64(0.86-3.13)
Emergency CS, adjusted OR (95% CI) 1.28 (0.82–1.99) 2.07 (1.35–3.17)*
Perinatal outcomes
Preterm birth, adjusted OR (95% CI) 1.71(0.87–3.36) 2.36(1.24–4.49)*
IUGR, adjusted OR (95% CI) 1.65(0.79–3.44) 1.53(0.77–3.01)
Small for gestational age, adjusted OR (95% CI) 1.47(0.82–2.64) 0.90(0.52–1.55)
Large for gestational age, adjusted OR (95% CI) 1.21(0.43–3.38) 3.45(1.20–9.96)*
Macrosomia, adjusted OR (95% CI) 0.77(0.26–2.33) 1.5(0.57–4.32)
Low birth weight, adjusted OR (95% CI) 1.63(0.77–3.46) 1.78(0.88–3.60)
NICU admission, adjusted OR (95% CI) 2.64(1.41–4.94)* 1.68(0.95-2.94)
Respiratory distress, adjusted OR (95% CI) 0.73(0.38–1.42) 1.35(0.73–2.50)
Neonatal hypoglycemia, adjusted OR (95% CI) 2.86(1.12–7.30)* 2.36(1.00-5.57)*
Perinatal mortality, adjusted OR (95% CI) 1.59 (0.29–8.70) 6.97(0.81–59.58)
GDM gestational diabetes mellitus, SC spontaneous conception, ART assisted reproductive technology, PIH pregnancy induced hypertension, IUGR Intrauterine
growth restriction, NICU neonatal intensive care unit
OR Crude Odds Ratio, CI Confidence Interval
ORs were adjusted for age, parity and pre-pregnancy body mass index
*P < 0.05 was considered significant
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